The use of prostatilen in treating patients with prostatic diseases
Observational study · 1991
- What was studied
- 37 patients with chronic prostatitis and 15 with prostatic adenoma
- Main finding
- Describes changes in symptoms, urinary measures and reproductive-function measures with Prostatilen.
Reported findings and study design
Prostatilen clinical report: 37 patients with chronic prostatitis and 15 with prostatic adenoma.
Population or model 37 patients with chronic prostatitis and 15 with prostatic adenoma
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Symptoms, uroflow and semen measures | Changes reported | Numerical outcome values and comparator data absent |
| Adverse reactions | None reported in this small study |
Values describe this study and its comparison. Unreported effect sizes and missing denominators have not been inferred.
Source for these results ↗ · Reviewed 2026-10-29
Study limitations and source details
Study limitations
- Small mixed clinical groups; control methods and adverse-event ascertainment unclear from the abstract.
- The tissue extract is not the synthetic peptide Prostamax.
Source details
Indexed abstract and citation checked via Europe PMC / PubMed; full methods and risk of bias not appraised.
Sources checked
Citation
Vozianov AF, Gorpinchenko II, Boĭko NI, Drannik GN, Khavinson VKh. The use of prostatilen in treating patients with prostatic diseases Urol Nefrol (Mosk) (6):43-46. PMID 1823683